tell how much of this really matters if we dont even have a product on the market?the company is more concerned in getting the tech into trials and having positve result from those trials, updating the fianacials yeah would be great but thats not gonna get one of there programs to patients bedside, we need postive results from the technology, its seems you dont trust the company, obvoius stem cell technology is way ahead of its time, look at Gern for example there a cash rich fully reporting company and thats got them no furthur along than us, well there the first approved by FDA but there SPrice is still the same, stem cell companys might not be you bag of tea, this could take a while in my opionion and if one cant be patient they might want to consider there options
Market Data 
Markets 
AI
